Analyst firms · BofA Securities · ILMN

BofA Securities ILMN price target and rating history

Illumina Inc. (ILMN) · Health Care

BofA Securities rates Illumina Inc. (ILMN) Underperform with a $100 price target, as of its latest action on Dec 12, 2023. It has published 3 rating actions on ILMN since January 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.

Current rating
Underperform
Price target
$100
Median target, all firms
$185
Actions on ILMN
3

BofA Securities price target on ILMN

$390$245$1002023202420252026
BofA Securities price target on ILMN, each point a stated target, January 2022 to December 2023.

Every BofA Securities rating on ILMN

How other firms rate ILMN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StephensEqual-Weight$275Oct 23, 2026
UBSBuy$260Sep 9, 2026
BernsteinMkt Perform$185Jun 26, 2026
RBC Capital MarketsOutperform$170May 15, 2026
DaiwaOutperform$155May 14, 2026

Questions about BofA Securities and ILMN

What is BofA Securities's price target for ILMN?
BofA Securities's latest stated price target for Illumina Inc. (ILMN) is $100, from its action on Dec 12, 2023.
What is BofA Securities's rating on ILMN?
BofA Securities rates ILMN Underperform, a bearish rating, as of Dec 12, 2023.
When did BofA Securities last change its view on ILMN?
On Dec 12, 2023, BofA Securities downgrades to Underperform from Neutral, price target $140 to $100.
How does BofA Securities's ILMN target compare with other analysts?
Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.

More ILMN rating histories

All BofA Securities ratingsILMN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.